Revolution Medicines (RVMD) Stock: Buy, Sell, or Hold?
RVMD - Revolution Medicines, Inc. Common Stock
$203.77
0.42 (0.21%)
â˛
5d:
-3.37%
30d:
-0.73%
90d:
+36.55%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 21, 2026 at $209.46 · last confirmed Sep 8, 2026
Strength: 5.5/10
Get Alerted When RVMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: RVMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: RVMD is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: RVMD is currently trading at $203.77, which is considered fair relative to its 30-day fair value range of $199.47 to $214.22.
Technical Outlook: Technically, RVMD is in a strong uptrend. The price is currently testing key support at $197.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RVMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $251.21 (+23.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RVMD is in a strong uptrend. The price is currently testing key support at $197.81. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RVMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $251.21 (+23.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$199.47 -
$214.22
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding RVMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.3% below Wall St target ($251.21)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$199.47 -
$214.22
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$197.81
Resistance Level
$221.50
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-34.23
Wall Street Target
$251.21
(+23.3%)
Revenue Growth (YoY)
-95.2%
Share & Embed Analysis
Last updated: September 12, 2026 6:14 AM ET
Data refreshes hourly during market hours. Next update: 7:14 AM
Data refreshes hourly during market hours. Next update: 7:14 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RVMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark A Goldsmith
SELL
120000 shares
2026-04-15
Jack Anders
SELL
2753 shares
2026-03-17
Lin Wei
SELL
2073 shares
2026-03-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical âĻ |
STRONG BUY
29 analysts |
$91 | 58 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 60 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 57 HOLD |
Advanced RVMD Option Strategies
Professional options setups generated by AI based on today's RVMD price and gamma walls.
